One substantial cause of high and growing health care spending is the cost of specialty drugs, particularly when delivered in a hospital outpatient setting.

The venture capital community is still struggling with exits and poor investments.

US drug spending remains high, with more expensive drugs continuing to come on the market particularly for weight loss and cancer.

I have too much stuff sitting around so just going to try to quickly clear some out.

A jobs report disappoints to the downside for once, but who knows how reliable the data is.

We are relearning a lot of basics about respiratory viruses that were forgotten during the epidemics.

The underlying rottenness of the US economy continues to poke through and is getting harder for the administration to hide.

If you look, you will find research that debunks climate hysteria.

Governments keep hiring more and more people who do little and get paid a lot.

Most Americans are unaware of how precarious the finances are of key programs they depend on, like Medicare.

A report illustrates some of the environmental damage caused by renewable energies, and overstates the harm from fossil fuels.

A few more research summaries as this series staggers to an end.

A little digression into some of Tom Wolfe's writings.

The economy is slowing and inflation accelerating while productivity declines. What a great combination.

The five-year US Treasury note runs into resistance in a weaker auction than that for the two-year note.